{"id":"W2029168581","doi":"10.1016/j.clgc.2013.09.002","title":"Six-Month Progression-Free Survival as the Primary Endpoint to Evaluate the Activity of New Agents as Second-line Therapy for Advanced Urothelial Carcinoma","year":2013,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Clinical endpoint; Oncology; Urothelial carcinoma; Internal medicine; Overall survival; Primary (astronomy); Urothelial cancer; Carcinoma; Second line; First line; Cancer; Clinical trial; Bladder cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001145213,0.0008080809,0.003128802,0.001418955,0.0001161554,0.0005891327,0.001022627,0.0006126769,0.002300301],"category_scores_gemma":[0.0008960885,0.0002069934,0.001962747,0.001314802,0.0002205267,0.0005789447,0.0002586263,0.001207144,0.0004104095],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000486872,"about_ca_system_score_gemma":0.0006188673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001032078,"about_ca_topic_score_gemma":0.004298051,"domain_scores_codex":[0.9996508,0.000112305,0.00007199554,0.00004371667,0.0001026245,0.0000185668],"domain_scores_gemma":[0.9993781,0.0003788285,0.0001239781,0.00001013964,0.00008905714,0.0000197845],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00111904,0.0002131302,0.000843411,0.07340023,0.003052497,0.00009597694,0.00006234627,0.0006354937,0.001689531,0.000685602,0.008025401,0.9101773],"study_design_scores_gemma":[0.004480139,0.008507696,0.03603315,0.07976041,0.03425026,0.003906248,0.0005198599,0.002379609,0.005182032,0.002896073,0.8218163,0.0002682363],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008979062,0.9984004,0.00008817751,0.00006737074,0.00006431388,0.00002202003,0.00006336663,0.000002929112,0.0003934675],"genre_scores_gemma":[0.008205031,0.9904097,0.0004576014,0.0002238757,0.00007131768,0.00003926022,0.0001607624,0.000002721371,0.0004296569],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003128802,"threshold_uncertainty_score":0.007695258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1740494188975193,"score_gpt":0.4790419817274608,"score_spread":0.3049925628299415,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}